Innovotech (IOTC.F) Stock Overview

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. More details

IOTC.F fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Earnings have declined by 18.1% per year over past 5 years

Shares are highly illiquid

Does not have a meaningful market cap ($5M)

Does not have meaningful revenue (CA$4M)

IOTC.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Innovotech Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Innovotech
Historical stock prices
Current Share Price	CA$0.097
52 Week High	CA$0.14
52 Week Low	CA$0.097
Beta	1.27
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-30.23%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	IOTC.F	US Life Sciences	US Market
7D	0%	2.0%	2.5%
1Y	n/a	5.3%	26.4%

Return vs Industry: Insufficient data to determine how IOTC.F performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how IOTC.F performed against the US Market.

Price Volatility

Is IOTC.F's price volatile compared to industry and market?
IOTC.F volatility
IOTC.F Average Weekly Movement	n/a
Life Sciences Industry Average Movement	8.1%
Market Average Movement	7.2%
10% most volatile stocks in US Market	16.5%
10% least volatile stocks in US Market	3.1%

Stable Share Price: IOTC.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine IOTC.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	16	Craig Milne	innovotech.ca

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services.

Innovotech Inc. Fundamentals Summary

How do Innovotech's earnings and revenue compare to its market cap?
IOTC.F fundamental statistics
Market cap	US$4.73m
Earnings (TTM)	-US$268.23k
Revenue (TTM)	US$2.91m

1.6x

P/S Ratio

-17.6x

P/E Ratio

Is IOTC.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IOTC.F income statement (TTM)
Revenue	CA$4.02m
Cost of Revenue	CA$2.09m
Gross Profit	CA$1.93m
Other Expenses	CA$2.30m
Earnings	-CA$370.47k

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0068
Gross Margin	48.00%
Net Profit Margin	-9.20%
Debt/Equity Ratio	5.0%

How did IOTC.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/05/26 13:22
End of Day Share Price	2026/05/19 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Innovotech Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.